Production (Stage)
Optimind Pharma Corp.
OMND
CNSX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 175.36% | 210.17% | 45.02% | -50.32% | -94.80% |
| Total Receivables | -60.85% | -61.96% | -50.97% | -62.86% | 38.24% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -25.02% | -15.05% | -24.18% | -54.32% | -71.74% |
|
|
|||||
| Total Current Assets | -25.02% | -15.05% | -24.18% | -54.32% | -71.74% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -20.97% | -74.22% | -75.64% | -77.87% | -82.37% |
|
|
|||||
| Total Accounts Payable | -41.85% | 24.01% | 342.79% | 359.35% | 162.15% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -5.94% | -78.68% | -77.03% | -76.22% | -75.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -29.60% | -62.64% | -57.49% | -25.21% | -41.05% |
|
|
|||||
| Total Current Liabilities | -29.60% | -62.64% | -57.49% | -25.21% | -41.05% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -5.94% | -78.68% | -77.03% | -76.22% | -75.00% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -29.60% | -63.12% | -62.09% | -33.83% | -48.48% |
|
|
|||||
| Common Stock & APIC | -0.35% | 14.31% | 18.37% | 10.96% | 11.75% |
| Retained Earnings | 1.74% | -17.94% | -25.08% | -27.98% | -41.14% |
| Treasury Stock & Other | -6.02% | -3.17% | 0.25% | -0.42% | -- |
| Total Common Equity | 45.43% | -140.76% | -117.92% | -156.33% | -120.23% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 45.43% | -140.76% | -117.92% | -156.33% | -120.23% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 45.43% | -140.76% | -117.92% | -156.33% | -120.23% |
|
|
|||||